Author:
Tamandjou Tchuem Cynthia Raissa,Auvigne Vincent,Vaux Sophie,Montagnat Charline,Paireau Juliette,Monnier Besnard Stéphanie,Gabet Amélie,Benhajkassen Nabil,Le Strat Yann,Parent Du Chatelet Isabelle,Levy-Bruhl Daniel
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference37 articles.
1. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta);Lopez Bernal;Variant N Engl J Med,2021
2. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France;Charmet;Lancet Reg Health Eur,2021
3. Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, et al. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med. 2021;27:1614-21. doi:10.1038/s41591-021-01446-y.
4. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021
5. Moline HL, Whitaker M, Deng L, Rhodes JC, Milucky J, Pham H, et al. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged >/=65 Years - COVID-NET, 13 States, February-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1088–93. doi:10.15585/mmwr.mm7032e3.